<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-biomedicines-08-00060">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shih</surname>
    <given-names>C.-S.</given-names>
   </name>
   <name>
    <surname>Laurie</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Holzmacher</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Spence</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Nathwani</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Davidoff</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Dyer</surname>
    <given-names>M.A.</given-names>
   </name>
  </person-group>
  <article-title>AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models</article-title>
  <source>Neuromol. Med.</source>
  <year>2009</year>
  <volume>11</volume>
  <fpage>43</fpage>
  <lpage>52</lpage>
  <pub-id pub-id-type="doi">10.1007/s12017-009-8059-0</pub-id>
  <?supplied-pmid 19306089?>
  <pub-id pub-id-type="pmid">19306089</pub-id>
 </element-citation>
</ref>
